A Phase II Safety and Efficacy Study of the Vascular...

Clinical Genitourinary Cancer 2013 / 12 Vol. 11; Iss. 4

A Phase II Safety and Efficacy Study of the Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor Pazopanib in Patients With Metastatic Urothelial Cancer

Pili, Roberto, Qin, Rui, Flynn, P.J., Picus, Joel, Millward, Michael, Ho, Wing Ming, Pitot, Henry, Tan, Winston, Miles, Kiersten M., Erlichman, Charles, Vaishampayan, Ulka
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
11
Language:
english
Journal:
Clinical Genitourinary Cancer
DOI:
10.1016/j.clgc.2013.05.005
Date:
December, 2013
File:
PDF, 791 KB
english, 2013
Conversion to is in progress
Conversion to is failed